![]() | |
Formerly |
|
---|---|
Company type | Société Anonyme |
| |
ISIN | FR0000120578 |
Industry | |
Founded | 1973 |
Headquarters | Paris, France |
Area served | Worldwide |
Key people |
|
Products | Medications, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...) |
Revenue | ![]() |
![]() | |
![]() | |
Total assets | ![]() |
Total equity | ![]() |
Number of employees | 86,088 (2023) |
Subsidiaries | |
Website | sanofi |
Footnotes / references [1] |
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index.[2] In 2023, the company’s seat in Forbes Global 2000 was 89.[3]
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines (it is the world's largest producer of the last through its subsidiary Sanofi Pasteur).[4]